Founder/operator background
Full P&L, EBITDA, M&A diligence, exit readiness, integration planning, and regulated workflow buildout.
About Azis
Azis Dabas builds the commercial infrastructure that healthtech founders need when early demand has to become a disciplined, launchable, measurable growth system.
The throughline is founder-grade operating ownership: co-founding and exiting a specialty pharmacy platform, building provider networks, translating payer and value-based-care economics into commercial decisions, and standing up the RevOps intelligence layer that lets leaders see what is working before revenue leaks.
Recent work has included focused interim and project-based commercial buildout mandates across behavioral health, multispecialty care, and dialysis - intentionally structured as high-intensity sprints to build growth systems, payer-aligned channels, and operating infrastructure.
Series A/B healthtech is the ideal fit because the company usually has enough product-market signal to matter, but not yet enough commercial operating discipline to make the market repeatable.
CEO/CFO view
A board-ready view of how market signal, payer economics, provider activation, RevOps control, and value proof stack into decisions a CEO and CFO can actually use.
$125.9M
Leakage opportunity
Claims and referral signal translated into targetable growth lanes.
$8M+
Built ARR
Regulated specialty pharmacy platform built from zero to strategic exit.
$13M+
Referral revenue
Annualized referral revenue across a dialysis network growth motion.
18%+
EBITDA discipline
Margin discipline maintained in a founder-to-exit build.
Full P&L, EBITDA, M&A diligence, exit readiness, integration planning, and regulated workflow buildout.
Medicare Advantage, Managed Medicaid, VBC, HEDIS/Stars, RAF/HCC, care gaps, provider networks, and service-line economics.
Databricks, SQL, Python, HubSpot, attribution, LTV/CAC, AI-assisted scoring, and claims/referral leakage intelligence.
Domains
Operating stack
Healthcare GTM operator who helps CEOs, CFOs, and founders turn messy healthcare markets into decisions: where the signal is real, how the economics work, what motion to run, what proof to require, and what to fund next.